AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.05
+0.15 (3.06%)
At close: Sep 18, 2026, 4:00 PM EDT
5.04
-0.01 (-0.20%)
After-hours: Sep 18, 2026, 7:30 PM EDT
AN2 Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Income Operating Income Growth | -8.9 | -10.55 | -9.32 | -10.04 | -7.22 | -11.54 | -8.61 | -11.77 | -15.88 | -18.3 | -18.82 | -18.18 | -16.6 | -16.04 | -12.48 | -11.77 | -10.33 | -7.68 | -7.59 | -6.93 |
Net Income Net Income Growth | -8.19 | -10.03 | -8.71 | -9.35 | -6.46 | -10.65 | -7.52 | -12.75 | -14.44 | -16.62 | -16.9 | -16.71 | -15.8 | -15.32 | -11.84 | -11.34 | -10.12 | -9.48 | -9.47 | -8.87 |
Earnings Per Share EPS Growth | -0.18 | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.79 | -0.61 | -0.59 | -0.53 | -2.98 | -3.57 | -3.35 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 78.39 | 85.29 | 58 | 61.92 | 62.92 | 67.06 | 83.62 | 93.43 | 104.54 | 114.21 | 107.3 | 123.82 | 95.26 | 88.52 | 96.06 | 104.38 | 113.39 | 118.35 | 58.56 | - |
Total Debt Total Debt Growth | - | - | - | - | - | - | - | - | - | - | - | - | 0.01 | 0.03 | 0.05 | 0.07 | 0.01 | 0.03 | - | - |
Net Cash (Debt) Net Cash Growth | 78.39 | 85.29 | 58 | 61.92 | 62.92 | 67.06 | 83.62 | 93.43 | 104.54 | 114.21 | 107.3 | 123.82 | 95.25 | 88.48 | 96.01 | 104.31 | 113.38 | 118.32 | 58.56 | - |
Net Cash Growth | 24.59% | 27.18% | -30.64% | -33.72% | -39.82% | -41.28% | -22.07% | -24.55% | 9.76% | 29.08% | 11.76% | 18.70% | -15.99% | -25.22% | 63.96% | - | - | 2807.17% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.75 | 2.50 | 1.91 | 2.05 | 2.09 | 2.23 | 2.80 | 3.13 | 3.51 | 3.84 | 3.61 | 4.83 | 4.88 | 4.56 | 4.96 | 5.39 | 5.89 | 37.20 | 22.06 | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -7 | -12.07 | -5.24 | -6.38 | -7.6 | -10.62 | -5.27 | -12.01 | -14.38 | -17.59 | -17.07 | -11.8 | -12.82 | -11.6 | -7.64 | -9.49 | -9.6 | -6.74 | -8.99 | -4.69 |
Free Cash Flow Free Cash Flow Growth | -7 | -12.07 | -5.24 | -6.38 | -7.6 | -10.62 | -5.27 | -12.01 | -14.38 | -17.59 | -17.07 | -11.8 | -12.82 | -11.6 | -7.64 | -9.49 | -9.6 | -6.74 | -8.99 | -4.69 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selected indicators aren't available for this stock.